228 related articles for article (PubMed ID: 30683858)
1. Runx/Cbfβ complexes protect group 2 innate lymphoid cells from exhausted-like hyporesponsiveness during allergic airway inflammation.
Miyamoto C; Kojo S; Yamashita M; Moro K; Lacaud G; Shiroguchi K; Taniuchi I; Ebihara T
Nat Commun; 2019 Jan; 10(1):447. PubMed ID: 30683858
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of type 2 innate lymphoid cells and T
De Grove KC; Provoost S; Hendriks RW; McKenzie ANJ; Seys LJM; Kumar S; Maes T; Brusselle GG; Joos GF
J Allergy Clin Immunol; 2017 Jan; 139(1):246-257.e4. PubMed ID: 27315767
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase Cθ controls type 2 innate lymphoid cell and T
Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D
J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M
J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144
[TBL] [Abstract][Full Text] [Related]
5. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation.
Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH
Front Immunol; 2021; 12():664218. PubMed ID: 34867937
[TBL] [Abstract][Full Text] [Related]
6. Enforced expression of Gata3 in T cells and group 2 innate lymphoid cells increases susceptibility to allergic airway inflammation in mice.
KleinJan A; Klein Wolterink RG; Levani Y; de Bruijn MJ; Hoogsteden HC; van Nimwegen M; Hendriks RW
J Immunol; 2014 Feb; 192(4):1385-94. PubMed ID: 24415780
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells.
Oczypok EA; Milutinovic PS; Alcorn JF; Khare A; Crum LT; Manni ML; Epperly MW; Pawluk AM; Ray A; Oury TD
J Allergy Clin Immunol; 2015 Sep; 136(3):747-756.e4. PubMed ID: 25930197
[TBL] [Abstract][Full Text] [Related]
8. Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells.
Klein Wolterink RG; Serafini N; van Nimwegen M; Vosshenrich CA; de Bruijn MJ; Fonseca Pereira D; Veiga Fernandes H; Hendriks RW; Di Santo JP
Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10240-5. PubMed ID: 23733962
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Group 2 Innate Lymphoid Cells in Allergic Airway Inflammation Models in the Mouse.
Li BWS; Beerens DMJM; Brem MD; Hendriks RW
Methods Mol Biol; 2017; 1559():169-183. PubMed ID: 28063044
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma.
Klein Wolterink RG; Kleinjan A; van Nimwegen M; Bergen I; de Bruijn M; Levani Y; Hendriks RW
Eur J Immunol; 2012 May; 42(5):1106-16. PubMed ID: 22539286
[TBL] [Abstract][Full Text] [Related]
11. Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate.
Thio CL; Chi PY; Lai AC; Chang YJ
J Allergy Clin Immunol; 2018 Dec; 142(6):1867-1883.e12. PubMed ID: 29522844
[TBL] [Abstract][Full Text] [Related]
12. Cutting Edge: Core Binding Factor β Is Required for Group 2 Innate Lymphoid Cell Activation.
Shen X; Liang M; Chen X; Pasha MA; D'Souza SS; Hidde K; Howard J; Sultana DA; Fung ITH; Ye L; Pan J; Liu G; Drake JR; Drake LA; Zhu J; Bhandoola A; Yang Q
J Immunol; 2019 Mar; 202(6):1669-1673. PubMed ID: 30728212
[TBL] [Abstract][Full Text] [Related]
13. Activation through toll-like receptor 2 on group 2 innate lymphoid cells can induce asthmatic characteristics.
Ishii T; Muroi M; Horiguchi K; Tanamoto KI; Nagase T; Yamashita N
Clin Exp Allergy; 2019 Dec; 49(12):1624-1632. PubMed ID: 31494992
[TBL] [Abstract][Full Text] [Related]
14. Epigenome analysis links gene regulatory elements in group 2 innate lymphocytes to asthma susceptibility.
Stadhouders R; Li BWS; de Bruijn MJW; Gomez A; Rao TN; Fehling HJ; van IJcken WFJ; Lim AI; Di Santo JP; Graf T; Hendriks RW
J Allergy Clin Immunol; 2018 Dec; 142(6):1793-1807. PubMed ID: 29486229
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic functional defects of type 2 innate lymphoid cells impair innate allergic inflammation in promyelocytic leukemia zinc finger (PLZF)-deficient mice.
Verhoef PA; Constantinides MG; McDonald BD; Urban JF; Sperling AI; Bendelac A
J Allergy Clin Immunol; 2016 Feb; 137(2):591-600.e1. PubMed ID: 26602165
[TBL] [Abstract][Full Text] [Related]
16. Group 2 innate lymphoid cells (ILC2s): The spotlight in asthma pathogenesis and lung tissue injury.
Sadik S; Lu Y; Zhu S; Cai J; Mi LL
Allergol Immunopathol (Madr); 2021; 49(2):208-216. PubMed ID: 33641310
[TBL] [Abstract][Full Text] [Related]
17. IL-10 production by ILC2s requires Blimp-1 and cMaf, modulates cellular metabolism, and ameliorates airway hyperreactivity.
Howard E; Lewis G; Galle-Treger L; Hurrell BP; Helou DG; Shafiei-Jahani P; Painter JD; Muench GA; Soroosh P; Akbari O
J Allergy Clin Immunol; 2021 Apr; 147(4):1281-1295.e5. PubMed ID: 32905799
[TBL] [Abstract][Full Text] [Related]
18. Exhausted-like Group 2 Innate Lymphoid Cells in Chronic Allergic Inflammation.
Ebihara T; Taniuchi I
Trends Immunol; 2019 Dec; 40(12):1095-1104. PubMed ID: 31735510
[TBL] [Abstract][Full Text] [Related]
19. Transcription Factors in the Development and Function of Group 2 Innate Lymphoid Cells.
Ebihara T; Taniuchi I
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30893794
[TBL] [Abstract][Full Text] [Related]
20. E-Protein Inhibition in ILC2 Development Shapes the Function of Mature ILC2s during Allergic Airway Inflammation.
Barshad G; Webb LM; Ting HA; Oyesola OO; Onyekwere OG; Lewis JJ; Rice EJ; Matheson MK; Sun XH; von Moltke J; Danko CG; Tait Wojno ED
J Immunol; 2022 Mar; 208(5):1007-1020. PubMed ID: 35181641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
